{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-029223","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2021-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.034171+00:00","generated_at":"2026-06-28T07:14:10.983454+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Enveric Biosciences appoints Avani Kanubaddi as President, lowers quorum to one-third","bullets":["Avani Kanubaddi, current COO since Dec 2020, appointed President effective Nov 15, 2021.","Board approved amendment to bylaws reducing stockholder quorum from majority to one-third.","Kanubaddi previously COO at NEXGEL and founder of Welmedix Healthcare.","Amendment is effective Nov 15, 2021; full text filed as Exhibit 3.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-029223","json":"https://secwatch.observer/filing/0001493152-21-029223.json","markdown":"https://secwatch.observer/filing/0001493152-21-029223.md","text":"https://secwatch.observer/filing/0001493152-21-029223.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315221029223/0001493152-21-029223-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315221029223/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T07:14:10.983454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"44aba27817","claim":"Avani Kanubaddi was appointed as President at Enveric Biosciences, Inc..","evidence_excerpt":"On November 15, 2021, Enveric Biosciences, Inc. (the “Company”) appointed Avani Kanubaddi, the Chief Operating Officer of the Company, to serve as the Company’s President, effective as of November 15, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/890821/000149315221029223/0001493152-21-029223-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}